During the past decade, Bakirkoy Training and Research Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 8 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 8 clinical trials were completed. i.e. 20.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bakirkoy Training and Research Hospital" #1 sponsor was "Bakirkoy Dr. Sadi Konuk Research and Training Hospital" with 38 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Istanbul Medeniyet University" with 2 trials sponsored and "SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bakirkoy Training and Research Hospital" #1 collaborator was "Bakirkoy Dr. Sadi Konuk Research and Training Hospital" with 2 trials as a collaborator, "Istanbul University" with 2 trials as a collaborator, "Istinye University" with 2 trials as a collaborator, "Liv Hospital (Ulus)" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Bakirkoy Training and Research Hospital" are "Covid19" (5 trials), "COVID-19 Pneumonia" (3 trials), "Surgery" (3 trials), "Orthopedic Disorder" (2 trials) and "Post Operative Pain" (2 trials). Many other conditions were trialed in "Bakirkoy Training and Research Hospital" in a lesser frequency.

Most popular intervention types in "Bakirkoy Training and Research Hospital" are "Drug" (23 trials), "Other" (16 trials), "Procedure" (16 trials), "Biological" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Pembrolizumab" (4 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bakirkoy Training and Research Hospital" are 49 trials for "All" genders, 19 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Bakirkoy Training and Research Hospital". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in Bakirkoy Training and Research Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bakirkoy Training and Research Hospital, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 22 trials that are defined as “Not Applicable".